Medication of Hydroxychloroquine, Remdesivir and Convalescent Plasma during the COVID-19 Pandemic in Germany—An Ethical Analysis
This paper aims to analyze the ethical challenges in experimental drug use during the early stage of the COVID-19 pandemic, using Germany as a case study. In Germany uniform ethical guidelines were available early on nationwide, which was considered as desirable by other states to reduce uncertainti...
Main Authors: | Katja Voit, Cristian Timmermann, Florian Steger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | International Journal of Environmental Research and Public Health |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-4601/18/11/5685 |
Similar Items
-
Stigma and Discrimination (SAD) at the Time of the SARS-CoV-2 Pandemic
by: Antonio Baldassarre, et al.
Published: (2020-08-01) -
Anxiety Level in Pre-hospital Emergency Medical Services Personnel during Corona Virus Disease-2019 Pandemic
by: Hüseyin Mutlu, et al.
Published: (2021-03-01) -
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2
by: Katya Uzunova, et al.
Published: (2020-11-01) -
A hospital-related outbreak of SARS-CoV-2 associated with variant Epsilon (B.1.429) in Taiwan: transmission potential and outbreak containment under intensified contact tracing, January–February 2021
by: Andrei R. Akhmetzhanov, et al.
Published: (2021-09-01) -
Hydroxychloroquine: A Familiar Agent to Combat the Pandemic of COVID-19
by: Vasilios M. Polymeropoulos
Published: (2020-04-01)